Targeting lipid nanoparticle mediated co-delivery of edaravone and kaempferol for amyotrophic lateral sclerosis therapy
Nanoscale · 2026
DOI: 10.1039/d6nr00300a ↗Kurz gefasst
Fachartikel in der Zeitschrift Nanoscale, 2026. Verfasst von Junrong Tian und 4 weiteren Autor:innen. Beteiligte Einrichtung: Sichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs, School of Life Science and Engineering, Southwest Jiaotong University,…. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Edaravone, Kaempferols, Nanoparticles. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Department of Science and Technology of Sichuan Province, Fundamental Research Funds for Central Universities of the Central South University.
Abstract (Originalsprache)
A cRGD-modified lipid nanomedicine encapsulating edaravone and kaempferol achieves BBB penetration and neuronal targeting. Nrf2/SLC7A11/GPX4 signaling was activated, inhibiting ferroptosis and neuronal damage, offering a strategy for ALS treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Sichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs, School of Life Science and Engineering, Southwest Jiaotong University, Chengdu, Sichuan 610031, P. R. China. Huilisun@swjtu.edu.cn.
- School of Life Sciences and Engineering, Chengdu Medical College, Chengdu, Sichuan 610500, P. R. China.
- Department of Neurology, Chengdu Wenjiang District People's Hospital, Chengdu, Sichuan 611130, P. R. China.
Förderung
- National Natural Science Foundation of China
- Department of Science and Technology of Sichuan Province
- Fundamental Research Funds for Central Universities of the Central South University
Zitieren
APA
Tian, J., Jin, Z., Chi, Y., Wang, P., & Sun, H. (2026). Targeting lipid nanoparticle mediated co-delivery of edaravone and kaempferol for amyotrophic lateral sclerosis therapy. Nanoscale. https://doi.org/10.1039/d6nr00300a
Vancouver
Tian J, Jin Z, Chi Y, Wang P, Sun H. Targeting lipid nanoparticle mediated co-delivery of edaravone and kaempferol for amyotrophic lateral sclerosis therapy. Nanoscale. 2026. doi:10.1039/d6nr00300a
BibTeX
@article{Tian2026,
author = {Tian, Junrong and Jin, Zhuanzhuan and Chi, Yike and Wang, Pu and Sun, Huili},
title = {Targeting lipid nanoparticle mediated co-delivery of edaravone and kaempferol for amyotrophic lateral sclerosis therapy},
journal = {Nanoscale},
year = {2026},
doi = {10.1039/d6nr00300a}
}
EUVIMED